MAP Pharmaceuticals mappharma.com


Public list: Pharma Startups (4740) Neuroscience Startups (942)

MAP Pharmaceuticals is a drug company focused on providing better treatments for patients with neurological diseases. Taking an integrated scientific approach, MAP Pharmaceuticals seeks to place better care into patients' hands by enhancing how proven drugs perform, through targeted dosing regimens and novel delivery systems. MAP Pharmaceuticals' goal is to develop treatments that provide patients with greater control, improved efficacy and fewer side effects. Development programs in neurolog...Show all

MAP Pharmaceuticals is a drug company focused on providing better treatments for patients with neurological diseases. Taking an integrated scientific approach, MAP Pharmaceuticals seeks to place better care into patients' hands by enhancing how prove...Show all

Company (Acquired)

Phone: 650-386-3100

Fax:

2400 Bayshore Parkway
Suite 200
Mountain View, 94043
California, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
MAP Pharmaceuticals $167.1M Jan 23, 2013
KAI Pharmaceuticals $63M Apr 11, 2012
Drais Pharmaceuticals $15M Jan 7, 2008
See all 22 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related MAP Pharmaceuticals Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 9 investors

Board Members

Competitors

Company Status Description Investors
See all 22 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Method of therapeutic administration of dhe to enable rapid relief of migraine while minimizing side effect profile Oct 23, 2015 Dec 05, 2017 Patent
Enhanced eductor design Nov 18, 2015 Apr 04, 2017 Patent
Dose counter with lockout mechanism Jan 15, 2014 Nov 01, 2016 Patent
8′-hydroxy-dihydroergotamine compounds and compositions Dec 19, 2013 Jul 19, 2016 Patent
Fluoroergoline analogs Aug 28, 2015 Jun 14, 2016 Patent
See all 60 patents